NCT04846036 - The KHENERGYC Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions

Mitochondrial DiseasesMitochondrial DNA tRNALeu(UUR) m.3243A<G MutationMELASSubacute Necrotizing Encephalomyelopathy

Interventions

DRUG

Sonlicromanol

Oral administration of sonlicromanol twice daily

DRUG

Placebo

Oral administration of matching placebo twice daily

Trial Locations (1)

Radboud University Medical Center, Nijmegen